Step-by-Step Guide to Medical Device Registration India for US Manufacturers: Secure Your CDSCO MD-14 Import License

Introduction: The Indian Medical Device Market Opportunity

India’s medical device sector represents one of the fastest-growing healthcare markets globally, valued at approximately USD 18 billion in 2026 and projected to reach USD 26–50 billion by 2030–2031 at a CAGR of 7–16%. With a population exceeding 1.4 billion, rising chronic disease prevalence, expanding hospital infrastructure, and government initiatives like the Production-Linked Incentive (PLI) scheme and National Medical Devices Policy, India offers unparalleled opportunities for foreign manufacturers.

US, European, Chinese, Japanese, and South Korean companies dominate high-tech segments such as cardiovascular, orthopedic, diagnostic imaging, and in-vitro diagnostics devices. Over 70–80% of advanced medical devices in India are currently imported, creating a prime window for global players seeking India Medical Device Regulatory Approval. However, compliance with the Central Drugs Standard Control Organization (CDSCO) under the Medical Devices Rules, 2017 (MDR 2017) is mandatory. The CDSCO Import License—granted via Form MD-15 following submission of Form MD-14—serves as the gateway for lawful importation and commercialization. This guide provides US manufacturers and other foreign entities with a clear, actionable roadmap to navigate CDSCO MD-14 Application requirements, minimize delays, and accelerate market entry.

What is MD-14 License in India?

The MD-14 License refers to the application form prescribed under Rule 34 of the MDR 2017 for obtaining an Import License for medical devices. Upon successful review, the CDSCO issues the actual Import License in Form MD-15. This perpetual license (subject to five-year retention fees) authorizes the import, sale, and distribution of specified medical devices in India. It applies to all risk classes (A, B, C, D) except certain low-risk Class A non-sterile, non-measuring devices that require only registration.

The MD-14 process ensures devices meet Indian safety, performance, and quality standards while aligning with international benchmarks from the US FDA, EU MDR, and other IMDRF members. For foreign manufacturers, the license is held by an Authorized Indian Agent, making the CDSCO Import License the critical regulatory milestone for Import Medical Devices to India.

Why Foreign Manufacturers Need CDSCO Approval

Without CDSCO approval, imported medical devices cannot clear customs or be marketed legally in India. Non-compliance risks shipment seizures, penalties, and reputational damage. CDSCO approval through the MD-14 pathway demonstrates that devices conform to essential principles of safety and performance, undergo appropriate quality management systems (QMS), and are supported by robust technical documentation. For US manufacturers, leveraging existing FDA clearances and Free Sale Certificates streamlines the process, often waiving redundant clinical investigations for devices already marketed in the US or other GHTF countries (US, EU, UK, Canada, Japan, Australia). This approval unlocks access to India’s tier-2 and tier-3 cities, government tenders, and private hospital chains—markets where demand for advanced US-made technologies is surging.

Step-by-Step MD-14 Application Process

1. Appoint an Authorized Indian Agent: The agent must hold a valid wholesale license (Form 20/21B) or manufacturing license/registration certificate (Form MD-42) under MDR 2017.
2. Register on the SUGAM Portal: Create an account at cdscomdonline.gov.in or nsws.gov.in.
3. Prepare and Compile Documentation: Gather all Fourth Schedule requirements (detailed below).
4. Pay Applicable Government Fees: Via online challan.
5. Submit Form MD-14 Online: Upload covering letter, application form, PoA, technical files, and supporting documents.
6. CDSCO Review and Query Resolution: Respond promptly to any queries raised via the portal.
7. Possible Overseas Site Inspection: CDSCO may inspect the manufacturing facility before or after approval.
8. Grant of Import License (Form MD-15): Issued within nine months if documentation is complete and satisfactory.
9. Post-Approval Compliance: Submit retention fees every five years; report post-market surveillance and adverse events.

The entire process is digital, transparent, and designed for efficiency when prepared correctly.

Documents Required for MD-14 License

A complete MD-14 submission includes:

• Covering letter and fee challan.
• Duly filled Form MD-14.
• Power of Attorney (PoA) with undertaking from the Authorized Indian Agent (authenticated by Indian Magistrate, Embassy, or apostille).
• Copy of the Authorized Agent’s wholesale/manufacturing license.
• Free Sale Certificate/Marketing Authorization from the country of origin (US FDA) and at least one GHTF country (notarized/apostilled).
• QMS certificate (ISO 13485 or equivalent) and Declaration of Conformity.
• Plant Master File (Appendix I, Fourth Schedule).
• Device Master File (Appendix II, Fourth Schedule), including executive summary, specifications, risk analysis, verification/validation data, biocompatibility, sterilization (if applicable), clinical evidence, and PMS data.
• Labeling and Instructions for Use (IFU).
• Any prior import license copy (if applicable for endorsement).

All foreign documents must be properly notarized or apostilled. Incomplete submissions are the leading cause of delays.

Government Fees and Approval Timeline

Fees (per Second Schedule, MDR 2017) are charged in USD:

• Class A (non-IVD): $1,000 per site + $50 per distinct device.
• Class B (non-IVD): $2,000 per site + $1,000 per device.
• Class C or D (non-IVD): $3,000 per site + $1,500 per device.

Retention fees apply every five years to maintain perpetual validity. The statutory timeline for grant of the Import License is nine months from application date, provided documents are complete. In practice, well-prepared applications from US manufacturers with strong FDA/CE data typically receive approval in 4–8 months. Major post-approval changes require 60-day approval; minor changes are notified within 30 days.

Device Classification in India (Class A, B, C, D)

Under the First Schedule of MDR 2017, devices are classified by risk:

• Class A: Low risk (e.g., bandages, manual surgical instruments, non-sterile/non-measuring devices). Many are exempt from full licensing but require registration.
• Class B: Low-moderate risk (e.g., blood pressure monitors, certain diagnostic devices).
• Class C: Moderate-high risk (e.g., ventilators, orthopedic implants).
• Class D: High risk (e.g., heart valves, implantable defibrillators).

Classification is determined by intended use, invasiveness, duration of contact, and energy source. CDSCO maintains publicly available risk-based classification lists. US manufacturers should verify their device’s Indian class against US FDA classification, as risk levels may differ slightly. Higher-risk Class C/D devices from non-GHTF countries may require local clinical investigation.

Role of Authorized Indian Agent

Foreign manufacturers cannot apply directly. The Authorized Indian Agent— an Indian entity with the requisite license—submits the MD-14, acts as the legal importer of record, manages customs clearance, coordinates post-market surveillance, reports adverse events within statutory timelines, and serves as the single point of contact with CDSCO. The PoA must explicitly empower the agent to handle regulatory obligations. Multiple agents are permitted, but a change in agent triggers a fresh MD-14 application. Selecting a reputable, experienced agent with proven CDSCO track record is essential for smooth India Medical Device Regulatory Approval.

Common Mistakes Foreign Manufacturers Make in CDSCO Applications

1. Submitting incomplete Device/Plant Master Files or omitting critical validation data.
2. Incorrect device classification leading to under- or over-documentation.
3. Improperly authenticated or outdated Power of Attorney and Free Sale Certificates.
4. Data mismatches between US FDA documents, portal entries, and labeling.
5. Failure to respond promptly to CDSCO queries via the SUGAM portal.
6. Non-compliant labeling (missing importer details, license number, or Indian language requirements).
7. Assuming US FDA 510(k) or PMA automatically waives all Indian requirements without supporting GHTF Free Sale Certificates.

These errors can add months and thousands in re-submission costs. Early engagement with regulatory experts prevents them.

Benefits of Entering the Indian Medical Device Market

Successful CDSCO approval delivers:

• Access to a market growing at double-digit rates with massive unmet demand.
• Participation in government procurement and insurance schemes.
• Cost-competitive manufacturing and distribution partnerships.
• Strategic gateway to South Asia and emerging markets.
• Long-term revenue diversification for US manufacturers facing domestic pricing pressures.

Early movers who secure MD-14 licenses today will capture significant share as India’s healthcare expenditure rises.

FAQ Section

1. Can US manufacturers apply directly for CDSCO Import License? No. An Authorized Indian Agent must submit the MD-14 application on your behalf.

2. How long does CDSCO MD-14 approval take? Up to nine months statutorily; typically 4–8 months with complete documentation.

3. Is clinical investigation always required for US-manufactured devices? No. Devices with Free Sale Certificates from the US or other GHTF countries are generally exempt for Class A/B and many Class C/D cases.

4. What is the validity of the Import License (MD-15)? Perpetual, subject to payment of retention fees every five years.

5. Are Class A devices fully exempt from licensing? Only non-sterile, non-measuring Class A devices require registration rather than full import licensing.

6. Can we use our existing FDA clearance for the Indian application? Yes—combined with Free Sale Certificate and technical documentation, it significantly strengthens the dossier.

7. What happens if we change our Authorized Indian Agent? A fresh MD-14 application is required; the previous license cannot be transferred.

8. Do we need separate approvals for each device variant or accessory? Devices are grouped where possible; each distinct medical device incurs per-device fees.

Conclusion Targeting Foreign Manufacturers

For US and other global medical device manufacturers, India is no longer optional—it is a strategic imperative. Mastering the MD-14 Import License process transforms regulatory complexity into competitive advantage. By following this step-by-step guide to Medical Device Registration India, companies can confidently navigate CDSCO requirements, accelerate time-to-market, and establish a sustainable presence in one of the world’s most promising healthcare economies.

Strong Call-to-Action

Ready to import medical devices to India? Our team of regulatory affairs consultants, specializing exclusively in CDSCO Import License and India Medical Device Regulatory Approval, offers end-to-end support—from Authorized Indian Agent appointment and dossier preparation to submission management and post-approval compliance. Contact us today for a free regulatory gap analysis and personalized MD-14 strategy tailored to your US-manufactured devices. Secure your competitive edge in the Indian market—schedule your consultation now.